harmol has been researched along with N-ethylharmine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Hu, CQ; Ishida, J; Lee, KH; Wang, HK | 1 |
| Cosentino, ML; Hu, CQ; Ishida, J; Lee, KH; Oyama, M; Wang, HK | 1 |
| Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M | 1 |
1 review(s) available for harmol and N-ethylharmine
| Article | Year |
|---|---|
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2018 |
2 other study(ies) available for harmol and N-ethylharmine
| Article | Year |
|---|---|
Antitumor agents 201. Cytotoxicity of harmine and beta-carboline analogs.
Topics: Antineoplastic Agents; Carbolines; Drug Screening Assays, Antitumor; Harmine; Humans; Tumor Cells, Cultured | 1999 |
Anti-AIDS agents. 46. Anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its derivatives.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Furans; Harmine; Humans; Lignans; Lymphocytes; Molecular Structure; Plants, Medicinal; Structure-Activity Relationship | 2001 |